Atenolol

Active ingredient description

Atenolol is a beta-blocker which is beta1-selective, (i.e. acts preferentially on beta1-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Atenolol
C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB03

Medicines

Atenolol is the active ingredient of these drugs:

Drug
Countries

Brazil

Hong Kong Singapore

Brazil

Ireland

Austria Cyprus Germany

Tunisia

Finland

Brazil

Brazil

South Africa

Brazil

Brazil

Austria

Ireland

Brazil

Tunisia

Hong Kong

Brazil

South Africa

Spain

Lithuania

Hong Kong

South Africa

Singapore

Tunisia

Tunisia

Hong Kong

Hong Kong

South Africa

Hong Kong Singapore

Hong Kong

Australia Hong Kong

Singapore

Italy

Hong Kong

Brazil Hong Kong

South Africa

Hong Kong

Singapore

New Zealand Singapore

Brazil

Australia

Italy

South Africa

Finland

Australia Austria Canada Cyprus Germany

France Tunisia

Hong Kong

Italy

Australia

Hong Kong

Hong Kong

Hong Kong

Cyprus Hong Kong

Cyprus Hong Kong Singapore Tunisia

Cyprus Singapore

South Africa

Atenolol is also found within below combination drugs:

ABLOK PLUS , ANGIPRESS CD , ATECOR CT , ATEHEXAL COMP , ATENETIC , ATENIDONE , ATENIGRON , ATENOCOMP , ATENOLAN-COMP , ATENORESE , BETA-NICARDIA , BETALOR , BLOKIUM-DIU , CLORTANOL , DIUBLOK , IGROSELES , KALTEN , NEATENOL DIU , NIF-TEN , NIFETEX , NIFTEN , PRETENOL C , REVERT , TARGET , TELOL C , TENCHLOR , TENERETIC , TENIF , TENORDATE , TENORET , TENORETIC , TRI-NORMIN , TYPOFEN

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

50VV3VW0TI - ATENOLOL

CAS registry number

29122-68-7 - atenolol

SNOMED-CT

387506000 - Atenolol (substance)